Jacques Bouchy

Jacques Bouchy heads investor relations and business development at Kineta. He has over thirty years of pharmaceutical industry experience at Fortune 500 pharmaceutical and smaller biotech companies. Mr. Bouchy led the execution of Kineta’s strategic partnerships with Pfizer and Genentech as well as other external collaborations.

Prior to joining Kineta in 2014, Mr. Bouchy held leadership roles within the commercial organizations of Fortune 500 pharmaceutical companies. At GSK, he led payer marketing, pricing strategy and contracting of several mid to late-stage respiratory assets. He led a team that planned and executed the successful payer launch of BREO® Ellipta for the U.S. market ($1.5B product in 2020). Mr. Bouchy started his career at Schering-Plough where he held roles of increasing responsibility in the sales and managed markets organizations as well as the Merck/Schering-Plough joint venture. As a Regional Director, he led a team across the western U.S. that was accountable for all managed care payers that generated annual product sales of ~$300M. Mr. Bouchy has successfully launched twelve new pharmaceutical products throughout his career. He currently serves on the BIO Biodefense Committee and previously served on the board of the ALA’s Washington Asthma Initiative. Mr. Bouchy earned a B.S. in Marketing from the University of Colorado.